FAQ

WY 49605

Known as: WY-49605 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-1997
01219941997

Related topics

Related topics

1 relation
SUN 5555

Related mentions per year

Related mentions per year

1989-1997
19801985199019952000
WY 49605
SUN 5555

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
Broth MIC and time-kill methodology was used to determine the activity of cefditoren relative to those of penicillin G… (More)
  • table I
  • table III
Is this relevant?
1995
1995
Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing.
The in vitro antimicrobial activity of an oral penem, WY-49605, was compared with those of six other oral antimicrobial agents… (More)
Is this relevant?
1995
1995
Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
The in vitro activity of WY-49605 (SUN5555) (WY) was compared with those of cefaclor, cefixime, and amoxicillin-clavulanic acid… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
1995
1995
In vitro activity of WY-49605, a penem antimicrobial.
The in vitro activity of the penem antimicrobial WY-49605 was compared with those of other agents available for oral… (More)
Is this relevant?
1995
1995
Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
This study examined bacteriostatic and bactericidal activities of oral and parenteral antibiotics for penicillin-susceptible and… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
1995
1995
Comparative in vitro activity of furopenem against aerobic bacteria isolated from pediatric patients.
The in vitro activity of the oral penem furopenem (WY-49605, 545555, SUN5555, and ALP201) was tested against clinical bacteria… (More)
Is this relevant?
1994
1994
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic…
The National Committee for Clinical Laboratory Standards agar dilution method was used to compare the in vitro activity of WY… (More)
Is this relevant?
1994
1994
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin…
In vitro susceptibility of 185 penicillin-susceptible and -resistant pneumococci to WY-49605, a new oral penem, was compared with… (More)
Is this relevant?